ACM
AVNS

Aster Capital Management’s Avanos Medical AVNS Stock Holding History

Aster Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-316
Closed -$4.76K – 1050
2025
Q1 		$4.76K Buy
+316
New +$4.93K ﹤0.01% 1126
2024
Q4 		– Sell
-47
Closed -$1.13K – 1125
2024
Q3 		$1.13K Buy
+47
New +$1.07K ﹤0.01% 1012

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Aster Capital Management's AVNS Position: Q2 2025 in Review

Aster Capital Management sold out of Avanos Medical (AVNS) in Q2 2025, closing a stake of 316 shares — an estimated $4.76K sold.

Aster Capital Management first reported a position in AVNS in Q3 2024 and held it in 2 quarters. The position peaked at $4.76K in Q1 2025. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2025.

  • Aster Capital Management reported no remaining Avanos Medical position as of Q2 2025 after selling out during the quarter.
  • Aster Capital Management sold 316 Avanos Medical shares in Q2 2025, an estimated $4.76K.
  • Aster Capital Management first reported a position in Avanos Medical in Q3 2024 and held it in 2 quarters.
  • Aster Capital Management's Avanos Medical position peaked at $4.76K in Q1 2025.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2025.

Based on Aster Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.